Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2019 | The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban | Kim Y.-H.; Shim J.; CHIA-TI TSAI ; Wang C.-C.; Vilela G.; Muengtaweepongsa S.; Kurniawan M.; Maskon O.; Hsu L.F.; Nguyen T.H.; Sim K.; Camm A.J. | Chest | 0 | 0 | |
2018 | XANAP: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in asia | Kim Y.-H.; Shim J.; CHIA-TI TSAI ; Wang C.-C.; Vilela G.; Muengtaweepongsa S.; Kurniawan M.; Maskon O.; Hsu L.F.; Nguyen T.H.; Thanachartwet T.; Sim K.; Camm A.J.; XANAP investigators | Journal of Arrhythmia | 17 | 15 |